
Sign up to save your podcasts
Or
Compounding medications allows physicians to customize formulations for individual patients. In this resident takeover, Daniel R. Mazori, MD, talks to Nadine Shabeeb, MD, MPH, about compounding topicals in dermatology. They discuss clinical scenarios in which these treatments may be warranted as well as potential drug combinations. “What’s cool about compounding for [conditions such as acne, rosacea, and hyperpigmentation] is that there are oftentimes multiple etiologies that lead to patients developing those conditions, and with compounding you can mix multiple things together to target some of those different factors,” Dr. Shabeeb says. They also discuss potential disadvantages and regulations for compounded medications.
* * *
This week in Dermatology News:
* * *
Key takeaways from this episode:
Hosts: Nick Andrews; Daniel R. Mazori, MD (State University of New York Downstate Medical Center, Brooklyn)
Guests: Nadine Shabeeb, MD, MPH (University of Wisconsin Hospital and Clinics, Madison)
Disclosures: Dr. Mazori reports no conflict of interest. Dr. Shabeeb reports no conflict of interest.
Show notes by: Alicia Sonners, Melissa Sears
* * *
You can find more of our podcasts at http://www.mdedge.com/podcasts
Email the show: [email protected]
Interact with us on Twitter: @MDedgeDerm
4.3
3636 ratings
Compounding medications allows physicians to customize formulations for individual patients. In this resident takeover, Daniel R. Mazori, MD, talks to Nadine Shabeeb, MD, MPH, about compounding topicals in dermatology. They discuss clinical scenarios in which these treatments may be warranted as well as potential drug combinations. “What’s cool about compounding for [conditions such as acne, rosacea, and hyperpigmentation] is that there are oftentimes multiple etiologies that lead to patients developing those conditions, and with compounding you can mix multiple things together to target some of those different factors,” Dr. Shabeeb says. They also discuss potential disadvantages and regulations for compounded medications.
* * *
This week in Dermatology News:
* * *
Key takeaways from this episode:
Hosts: Nick Andrews; Daniel R. Mazori, MD (State University of New York Downstate Medical Center, Brooklyn)
Guests: Nadine Shabeeb, MD, MPH (University of Wisconsin Hospital and Clinics, Madison)
Disclosures: Dr. Mazori reports no conflict of interest. Dr. Shabeeb reports no conflict of interest.
Show notes by: Alicia Sonners, Melissa Sears
* * *
You can find more of our podcasts at http://www.mdedge.com/podcasts
Email the show: [email protected]
Interact with us on Twitter: @MDedgeDerm
14 Listeners